China Medical System Holdings Ltd (867):企業の財務・戦略的SWOT分析

◆英語タイトル:China Medical System Holdings Ltd (867) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15140
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥33,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
China Medical System Holdings Ltd (CMS) is a pharmaceutical service provider that markets, promotes, and sells prescription drugs to all therapeutic departments in hospitals. The company offers products such as deanxit, ursofalk, augentropfen stulln mono eye-drops, exacin, xinhuosu, salofalk, bioflor, ganfule, and cystistat. It also offers shaduolika, yinuoshu, xidakang and astragalus. CMS partners include AstraZenca, H.Lundbeck A/S, Dr.Falk Pharma Gmbh, Bicodex, Pharma Stulln Gmbh, DKSH. Nordmark Arzneimittel GmbH & Co. KG. It has pharmaceutical manufacturing sites in Shenzhen, Hunan and Hebei Province. The company serves physicians, patients and specialty pharmaceutical companies. CMS is headquartered in Shenzhen, China.

China Medical System Holdings Ltd Key Recent Developments

Mar 06,2019: CMS Administrator Appoints Chief Healthcare Informatics Officer
Mar 05,2019: RepScrubs® Appoints Former CMS Administrative Director, Charlene Frizzera to Advisory Board to …
Mar 04,2019: CMS Selects Four Firms for Potential $1.5B Healthcare Service Review IDIQ
Feb 28,2019: CMS appoints 1st chief health informatics officer: 5 things to know
Feb 26,2019: Umbraco Launches Version 8 of Open-Source Friendly CMS

This comprehensive SWOT profile of China Medical System Holdings Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of China Medical System Holdings Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

China Medical System Holdings Ltd – Key Information
China Medical System Holdings Ltd – Overview
China Medical System Holdings Ltd – Key Employees
China Medical System Holdings Ltd – Key Employee Biographies
China Medical System Holdings Ltd – Key Operational Heads
China Medical System Holdings Ltd – Major Products and Services
China Medical System Holdings Ltd – History
China Medical System Holdings Ltd – Company Statement
China Medical System Holdings Ltd – Locations And Subsidiaries
China Medical System Holdings Ltd – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

China Medical System Holdings Ltd – Business Description
China Medical System Holdings Ltd – Corporate Strategy
China Medical System Holdings Ltd – SWOT Analysis
SWOT Analysis – Overview
China Medical System Holdings Ltd – Strengths
China Medical System Holdings Ltd – Weaknesses
China Medical System Holdings Ltd – Opportunities
China Medical System Holdings Ltd – Threats
China Medical System Holdings Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

China Medical System Holdings Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

China Medical System Holdings Ltd, Key Information
China Medical System Holdings Ltd, Key Ratios
China Medical System Holdings Ltd, Share Data
China Medical System Holdings Ltd, Major Products and Services
China Medical System Holdings Ltd, History
China Medical System Holdings Ltd, Key Employees
China Medical System Holdings Ltd, Key Employee Biographies
China Medical System Holdings Ltd, Key Operational Heads
China Medical System Holdings Ltd, Other Locations
China Medical System Holdings Ltd, Subsidiaries
China Medical System Holdings Ltd, Key Manufacturing facilities
China Medical System Holdings Ltd, Key Competitors
China Medical System Holdings Ltd, SWOT Analysis
China Medical System Holdings Ltd, Ratios based on current share price
China Medical System Holdings Ltd, Annual Ratios
China Medical System Holdings Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

China Medical System Holdings Ltd, Performance Chart
China Medical System Holdings Ltd, Ratio Charts

★海外企業調査レポート[China Medical System Holdings Ltd (867):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Jacobs Engineering Group Inc (JEC)-エネルギー分野:企業M&A・提携分析
    Summary Jacobs Engineering Group Inc. (Jacobs) is a provider of technical professional services. The company offers a diverse range of technical, professional, and construction services to industrial, commercial, and governmental customers across the globe. Its service portfolio includes project; pr …
  • Alibaba Pictures Group Limited:企業のM&A・事業提携・投資動向
    Alibaba Pictures Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Alibaba Pictures Group Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Blue Sky Uranium Corp. (BSK):企業の財務・戦略的SWOT分析
    Blue Sky Uranium Corp. (BSK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Probiodrug AG (PBD):製薬・医療:M&Aディール及び事業提携情報
    Summary Probiodrug AG (Probiodrug) is a clinical stage biopharmaceutical company that conducts research and development of new medicines for the treatment of Alzheimer’s disease. The company provides three pipeline drug candidates such as PQ912, PBD-C06 and PQ1565. Its PQ912 drug candidate is a smal …
  • Camargo Correa Sa:企業の戦略・SWOT・財務分析
    Camargo Correa Sa - Strategy, SWOT and Corporate Finance Report Summary Camargo Correa Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Nissin Foods Holdings Co Ltd.:企業の戦略・SWOT・財務分析
    Nissin Foods Holdings Co Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nissin Foods Holdings Co Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Nohla Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Nohla Therapeutics Inc (Nohla Therapeutics) focuses on the development of universal, off-the-shelf cell therapies for the treatment of hematologic malignancies and other critical diseases. The company develops clinical, preclinical and discovery programs based on its proprietary notch ligand …
  • PricewaterhouseCoopers International Limited:企業の戦略・SWOT・財務情報
    PricewaterhouseCoopers International Limited - Strategy, SWOT and Corporate Finance Report Summary PricewaterhouseCoopers International Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Carmot Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Carmot Therapeutics Inc (Carmot Therapeutics) is a biotechnology company which discovers and develops drugs for the treatment of cancer, inflammation and metabolic diseases. The company’s product portfolio encompasses investigational candidates in preclinical trials: peptide-small molecule h …
  • Evonik Industries AG:企業の戦略・SWOT・財務情報
    Evonik Industries AG - Strategy, SWOT and Corporate Finance Report Summary Evonik Industries AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Jounce Therapeutics Inc (JNCE):製薬・医療:M&Aディール及び事業提携情報
    Summary Jounce Therapeutics Inc (Jounce) is a clinical stage immunotherapy company that develops therapies that enable the immune system to attack tumors. The company provides JTX-2011, an anti-ICOS monoclonal antibody which stimulates T effector cells to enhance anti-tumor activity; JTX-4014, an an …
  • Cummins Inc (CMI)-エネルギー分野:企業M&A・提携分析
    Summary Cummins Inc. (Cummins) is a manufacturer of diesel engines and related technologies. It designs, manufactures, services and distributes engines and related component solutions. The company offers filtration, fuel systems, control systems, after treatment devices, turbochargers, air handling …
  • Salesforce.Com Inc (CRM):企業の財務・戦略的SWOT分析
    Salesforce.Com Inc (CRM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Facebook Inc.:企業の戦略・SWOT・財務分析
    Facebook Inc. - Strategy, SWOT and Corporate Finance Report Summary Facebook Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • MediPal Holdings Corp:企業の戦略・SWOT・財務情報
    MediPal Holdings Corp - Strategy, SWOT and Corporate Finance Report Summary MediPal Holdings Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Airbnb Inc:企業の戦略・SWOT・財務情報
    Airbnb Inc - Strategy, SWOT and Corporate Finance Report Summary Airbnb Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • NorthWestern Corp (NWE):石油・ガス:M&Aディール及び事業提携情報
    Summary NorthWestern Corp, doing business as NorthWestern Energy, is an electric and natural gas utility. It generates, transmits, and electricity, and also carries out mid-stream operations. The company produces from wind, hydro, solar, coal, and natural gas. NorthWestern Energy produces, stores, t …
  • LIG Nex1 Co., Ltd.:企業の戦略・SWOT・財務情報
    LIG Nex1 Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary LIG Nex1 Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Termas De Puyehue S.A.
    Termas De Puyehue S.A. - Strategy, SWOT and Corporate Finance Report Summary Termas De Puyehue S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • AngioDynamics Inc (ANGO):医療機器:M&Aディール及び事業提携情報
    Summary AngioDynamics Inc (AngioDynamics) is a provider of minimally invasive medical, surgical and diagnostic devices. Its product portfolio encompasses peripheral vascular products, radiofrequency ablation and NanoKnife systems, vascular access products, angiographic products and accessories, prod …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆